| |
HCV Guidelines Update July 6 2016
|
| |
| |
http://www.hcvguidelines.org/
What's New and Updates/Changes
Wednesday, July 6, 2016
This version of the Guidance has been updated to reflect several important developments, including the recent approval of sofosbuvir/velpatasvir, together with new information regarding the use of testing for HCV resistance associated variants.
What's New and Updates/Changes:
This version of the Guidance has been updated to reflect several important developments, including the recent approval of sofosbuvir/velpatasvir, together with new information regarding the use of testing for HCV resistance associated variants. Click here for list of all updated sections.
What's New and Updates/Changes
This version of the Guidance has been updated to reflect several important developments, including the recent approval of sofosbuvir/velpatasvir, together with new information regarding the use of testing for HCV resistance associated variants.
Updated recommendations reflecting this approval are provided in these sections:
Initial Treatment of HCV Infection
Retreatment of Persons in Whom Prior Therapy has Failed
Unique Patient Populations: Patients with Decompensated Cirrhosis
Other updates reflecting recent data are provided in:
Unique Patient Populations: Patients who Develop Recurrent HCV Infection Post-Liver Transplantation
Unique Patient Populations: Patients with HIV/HCV Coinfection
Unique Patient Populations: Patients with Renal Impairment
HCV Testing and Linkage to Care
Updated recommendations regarding the monitoring of cirrhotic patients are also provided in:
Monitoring Patients Who Are Starting Hepatitis C Treatment, Are On Treatment, or Have Completed Therapy
Drug-drug interaction updates are also provided, particularly as they relate to antiretroviral agents and calcineurin inhibitors in:
Unique Patient Populations: Patients with HIV/HCV Coinfection
Unique Patient Populations: Patients who Develop Recurrent HCV Infection Post-Liver Transplantation
Updated references have been provided throughout the Guidance.
http://www.hcvguidelines.org/full-report/initial-treatment-hcv-infection
|
|
| |
| |
|
|
|
